Key points are not available for this paper at this time.
Aminoglycosides are highly potent, broad-spectrum antibiotics with many desirable properties for the treatment of life-threatening infections (281). Their history begins in 1944 with streptomycin and was thereafter marked by the successive introduction of a series of milestone compounds (
Mingeot‐Leclercq et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: